MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health
-
Upload
francois-stepman -
Category
Documents
-
view
385 -
download
1
description
Transcript of MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health
![Page 1: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/1.jpg)
Prof. dr. Siska CROUBELS
Department of Pharmacology, Toxicology and Biochemistry
Faculty of Veterinary Medicine – Ghent University
IPV VVZ – 04.09.2014
MYCOTOXINS and ANIMAL HEALTH:focus on intestinal health
www.mytox.be
![Page 2: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/2.jpg)
Mycotoxins:
• Introduction• Occurrence in animal feed• Effects in animals
• General• Specific (aflatoxin B1, DON, T2-toxin, zearalenone,
fumonisins, ochratoxin A)• Effects on intestinal barrier function• Consequences of impaired barrier function
• Interaction with intestinal pathogens• Absorption of nutrients• Absorption of veterinary drugs (antibiotics)
• Transfer factors of residues to animal food products
OUTLINE
![Page 3: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/3.jpg)
Mycotoxin research:
• Toxicity (cell viability)• Toxicokinetics (ADME) of (masked) mycotoxins• Tissue residues• Interaction with pathogens
• Salmonella Typhimurium• Clostridium perfringens• Escherichia coli
• Interaction with pharmacokinetics of veterinary drugs• Efficacy testing of mycotoxin binders
LABORATORY OF PHARMACOLOGY & TOXICOLOGY
![Page 4: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/4.jpg)
2012
![Page 5: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/5.jpg)
OCCURRENCE OF MYCOTOXINS IN EUROPEAN CEREALS
Streit et al., 2013
Analysis with LC-MS/MS 83 samples of feed and feed raw materials
![Page 6: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/6.jpg)
OCCURRENCE OF MYCOTOXINS IN EUROPEAN CEREALS
Streit et al., 2013
Analysis with LC-MS/MS 83 samples of feed and feed raw materials
![Page 7: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/7.jpg)
OCCURRENCE OF MYCOTOXINS IN EUROPEAN CEREALS
Global surveyfeed and feed ingredients (2004-2011)
55% DON54% fumonisins 36% ZEN
most of samples comply with EU regulations or recommendations on the maximal tolerable concentration(2002/32/EC, 2006/576/EC and 2013/165/EC)
mg/kg feed DON T-2 and HT-2 ZEN FB1+FB2 AFB1 OTA
Poultry 5.0 0.25 --- 20 0.02 0.10
Pigs 0.9 0.25 0.10 5 0.02 0.05
Calves 2.0 0.25 0.50 20 0.02 ---
Adult ruminants
5.0 0.25 0.50 50 0.02(dairy 0.005)
---
problem of co-contamination?
![Page 8: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/8.jpg)
Pig reduced performancereduced feed utilization and efficiencyimpaired fertilityskin lesions
Poultry reduced performance“fatty liver” syndromedecreased egg productionpoor carcass quality
Cattle reduced milk yieldimpaired fertilitymastitisketonuria
Horse neurotoxic syndrome
Subclinical doses: immunosuppressive effects
CLINICAL EFFECTS IN ANIMALS
![Page 9: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/9.jpg)
Dependent on
- type and dose
- duration of exposure
- species, gender, age, health status
- synergistic effects (single vs. multiple toxins)
www.efsa.eu.intwww.knowmycotoxins.com
www.thepoultrysite.comwww.mycotoxins.info
CLINICAL EFFECTS IN ANIMALS
![Page 10: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/10.jpg)
EFFECTS OF MYCOTOXINS
www.mycotoxins.info
![Page 11: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/11.jpg)
EFFECTS OF MYCOTOXINS
www.mycotoxins.info
![Page 12: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/12.jpg)
EFFECTS OF MYCOTOXINS
www.mycotoxins.info
![Page 13: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/13.jpg)
META-ANALYSIS FOR INTERACTIONS OF MYCOTOXINS WITH PERFORMANCE IN BROILERS
Andretta et al., 2011
98 papers between 1980-2009, in total 1,401 diets and 37,371 birds
Mycotoxins Ochratoxins Aflatoxins Deoxynivalenol (DON)
Feed intake reduction
12% 17% 11%
Weight gain reduction
14% 20% 11%
Mortalityincrease
2.8x 8.5x
Mycotoxins influence broiler performance, productive indices and organ weight, magnitude dependent on:
type and concentrationduration of exposureanimal age
nutritional factors
![Page 14: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/14.jpg)
AFLATOXINS
Aflatoxin B1 most toxic (blue fluorescence, UV-light)carcinogen (a.o. rat, duck, trout fish)IARC class 1 - Ames test and inactivation of tumour suppressor p53 gene(mutation at codon 249)
Aflatoxin B2 dihydro derivative, less toxic (+/- 20%)potentialises B1
![Page 15: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/15.jpg)
AFLATOXINS
ToxicokineticsOral bioavailability: about 100%Biotransformation: AFB-8,9 epoxidation (liver enzymes CYP450) Elimination: urinary, biliary and milk (1-6%)
![Page 16: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/16.jpg)
AFLATOXINS
Symptoms and lesionsA. Acute aflatoxicosis
massive intake anorexia, depression, malabsorption, bloody stools, acute liver degeneration
icterus and secundary hemorrhages (vit. K1 treatment)
B. Chronic exposure production losses
icterus, ‘pale bird syndrome’hepatocellular carcinoma liver function impairmentimmunosuppression (Salmonella, Coccidia, …)
milk: aflatoxin M1 toxicity ~ aflatoxin B1
EU: 0.05 µg/kg AFM1 in raw milk, heat-treated milk and milk manufactured for milk-based products (ALARA, Commission Regulation (EU) No 165/2010)
Residues in food
![Page 17: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/17.jpg)
2013-2014
![Page 18: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/18.jpg)
TRICHOTHECENES: DON and T2-TOXIN ToxicokineticsOral bioavailability DON: 20-25% (broiler chicken) and 55-80% (pigs)Biotransformation: de-epoxidationExcretion: urinary and biliary
T2-toxin DON
ToxicityInhibition protein synthesisIncrease cytokine release (IL-6)Increase IgA, decrease IgG, IgMIARC class 3
![Page 19: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/19.jpg)
Symptoms
DON
in pigs “Abdominal distress syndrome”
vomiting and/or anorexia, diarrhea (from 2000 ppb)feed refusal (from1200 ppb)reduced feed intake (from1000 ppb)immunosuppression (from100 ppb?)
TRICHOTHECENES: DON
![Page 20: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/20.jpg)
Symptoms
“Alimentary toxic aleukia (ALTA)”
radiomimetic effectleukopenia, thrombocytopenia, cell necrosis(dermatitis, conjunctivitis, stomatitis, gastro-enteritis) hemorrhagic diathesisimmunosuppression
TRICHOTHECENES: T2-TOXIN
Bron: Prof. J. Fink-Gremmels
![Page 21: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/21.jpg)
Fusarium graminearum, F. culmorumMaize, wheat, corn cob mix
Symptoms
hyperoestrogenism, swollen edematous vulva, uterus prolapse, rectal prolapse, vulvovaginitis, atrophy of the ovaries, ...
mainly reproduction problems
Sensitive species: pig, sheep, dog, cattle
ZEARALENONE
![Page 22: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/22.jpg)
ToxicokineticsOral bioavailability: 80-85%Biotransformation: reduction to ,-zearalenol, further to -zearalanol (zeranol) and -zearalanol (taleranol)Excretion: urinary and biliary
Binds on oestrogen receptors ER and ER-zearalenol factor 138 uterotrophicity-zearalenol factor 0.5
IARC class 3
ZEARALENONE
![Page 23: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/23.jpg)
FUMONISINS
PathogenesisOral bioavailability: 3-6%1. Inhibition sfinganine N-acyltransferase (ceramid synthase)2. Increase sfinganine and sfinganine/sfingosine ratio
(Sa/So in serum, urine and tissues)IARC class 2B, oesophageal and hepatic cancer
![Page 24: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/24.jpg)
Symptoms
1. horseequine leucoencephalomalacia (ELEM)necrosis in cerebrum(ataxia, paresis, apathia, coma)+ liver pathology
2. pigpulmonary porcine edema (PPE)
lung edema, hydrothorax + liver- and pancreas pathology
3. broiler chickensmotor disturbances, immunosuppressionLOAEL: 2 mg/kg BW/day for broilers
FUMONISINS
ELEM horse
![Page 25: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/25.jpg)
OCHRATOXINS: OCHRATOXIN A
ToxicokineticsOral bioavailability: +/- 65 %96 to 99.8 % plasma protein bindingOTA is substrate for oatp (renal accumulation)Excretion: urinary and biliary, milk (monogastric animals and humans, cattle < 1%) IARC class 2B
pig (MPN = mycotoxic porcine nephropathy)inhibition of protein synthesisrenal pathologies, e.g. Balkan endemic nephropathy (BEN)
urinary tract tumours, nephritis, renal karyomegaly
![Page 26: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/26.jpg)
Small intestine:• Absorption of water and nutrients• Dynamic barrier
GASTROINTESTINAL TRACT: FIRST TARGET FOR MYCOTOXINS
![Page 27: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/27.jpg)
inte
stin
al
epit
hel
ium
lamina propria
gut lumen
intestinal permeability
↑ by DON, FB1
cell proliferation↓ by DON, T-2, FB1,
OTA and AFB1mucus production
↓ by DON + T-2 + ZEN↑ ZEN alone
sIgA
IEC goblet cell paneth cell
plasmocyte secreting Ig
IgA production↑ by DON and
nivalenol, ↓ by T-2 antimicrobial peptidesunknown
alter cytokines productionDON, T-2, nivalenol, FB1,
ZEN, patulin, gliotoxin
Antonissen et al., 2014Bouhet and Oswald, 2005
![Page 28: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/28.jpg)
MODULATION OF INTESTINAL FUNCTIONS BY MYCOTOXINS: META-ANALYSIS
Grenier and Applegate, 2013
about 100 papers, in total 7 intestinal processes were investigated
Mycotoxins, in particular DON, at realistic doses can compromise digestion, absorption, permeability and defense
![Page 29: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/29.jpg)
EFFECTS ON INTESTINAL BARRIER FUNCTION
Analyze the effects on the intestinal barrier function
- gut wall morphology- measurement of the transepithelial electrical resistance (TEER)
Identify the underlying mechanisms
- tight junction proteins- oxidative stress markers- inflammatory proteins- nutrient and xenobiotic transporter proteins- biotransformation enzymes
Consequences of an altered barrier function
- passage of macromolecules and bacteria
→ results obtained from swine and poultry
![Page 30: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/30.jpg)
Mycotoxin T-2 DON ZEA FB1
Cytotoxic concentration
3 ng/ml 2.5 µg/ml 9 µg/ml 20 µg/mlmost toxic
IN VITRO VIABILITY OF ENTEROCYTES
Goossens et al., 2012
Concentration-dependent effect on viability of intestinal porcine epithelial cells derived from the jejunum
Importance: cell death may result in damage to intestinal barrier
![Page 31: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/31.jpg)
DON DECREASES VILLUS HEIGHT IN BROILERS
Control DON
Duodenum (µm)
1734 ± 26 a 1449 ± 31 b
Jejunum(µm)
1343 ± 37 a 1184 ± 48 b
Ileum (µm)
596 ± 30 a 616 ± 38 a
DON ≤ 5 mg/kg (2006/576/EC)3 weeks feeding trial
Antonissen et al., 2014; Böhm et al., 2006; Yunus et al., 2012
DON > 5 mg/kg3 weeks feeding trial
Osselaere et al., 2013;Awad et al., 2006
Duodenum
*
![Page 32: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/32.jpg)
DON DECREASES VILLUS HEIGHT IN TURKEYS
DON ± 5 mg/kg (2006/576/EC)12 weeks feeding trial
Devreese et al., 2014
*
![Page 33: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/33.jpg)
T2-TOXIN DECREASES VILLUS HEIGHT IN PIGS
T2 ≤ 250 µg/kg (2013/165/EC)3 weeks feeding trial
Goossens et al., 2013
![Page 34: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/34.jpg)
DON DECREASES INTESTINAL GENE EXPRESSION OF TIGHT JUNCTION PROTEINS IN BROILERS
Protocol•one-day-old broilers fed for 3 weeks with DON at 7.5 mg/kg, incl. adsorbing agent (binder)•sections from duodenum, jejunum and ileum•qRT-PCR analysis for CLDN1, CLDN5, ZO1, ZO2
Tight junctions:•Duodenum: no effects•Jejunum:
Osselaere et al., 2013
![Page 35: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/35.jpg)
DON DECREASES INTESTINAL EXPRESSION OF TIGHT JUNCTION PROTEINS IN PIGS
Pinton et al., 2009Oswald, 2013
![Page 36: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/36.jpg)
MYCOTOXINS IMPAIR INTESTINAL BARRIER
Altered intestinal functions:CONSEQUENCES?
Enhanced susceptibility to enteric infections?
Altered digestion and absorption of nutrients?
Altered absorption of veterinary drugs and feed additives?
![Page 37: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/37.jpg)
CONSEQUENCES: SUSCEPTIBILITY TO ENTERIC INFECTIONS
Deoxynivalenol and also fumonisins predispose for the development of necrotic enteritis in broilers
Experimental in vivo model for subclinical necrotic enteritis
Fig. Leen Timbermont
Fig. Gunther Antonissen
Antonissen et al., 2014
Experimental groups:
1.C. perfringens + control diet2.C. perfringens + fumonisins3.C. perfringens + fumonisins + DON4.C. perfringens + DON
Concentration DON: +/- 4 mg/kg feed and fumonisins +/- 20 mg/kg feed Fig. Leen Timbermont
Fig. Gunther Antonissen
![Page 38: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/38.jpg)
predisposing for necrotic enteritis?RESULTS
CONSEQUENCES: SUSCEPTIBILITY TO ENTERIC INFECTIONS
![Page 39: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/39.jpg)
CONSEQUENCES: SUSCEPTIBILITY TO ENTERIC INFECTIONS
Influence of mycotoxin contamination on intestinal protein availability for clostridial proliferation
Antonissen et al., 2014
![Page 40: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/40.jpg)
CONSEQUENCES: SUSCEPTIBILITY TO ENTERIC INFECTIONS
Antonissen et al., 2014
![Page 41: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/41.jpg)
Fusarium mycotoxins intestinal and systemic phase of the pathogenesis of Salmonella Typhimurium
gut lumen
lamina propria
1
2
3
4
inte
stina
l ep
ithel
ial
cell
mac
roph
age
DON and T-2
3 ↑ macrophage invasion
4no effect intracellular bacterial proliferation
Vandenbroucke et al., 2009; Verbrugghe et al., 2012
1↑ intestinal Salmonella invasion
2↑ passage Salmonella across epithelium
CONSEQUENCES: SUSCEPTIBILITY TO INFECTIONS
![Page 42: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/42.jpg)
42
control diet DON diet≈ 5 mg/kg
fumonisins diet
≈ 20 mg/kg FB1+FB2+FB3
DON + fumonisins diet
≈ 5 mg/kg and 20 mg/kg
Ross 308224 chicks
4 groups(56 birds/group)
CONSEQUENCES: ABSORPTION OF NUTRIENTS
![Page 43: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/43.jpg)
b0,+AT Na+-independent neutral and dibasic amino acid transporterrBAT protein related to b0,+ATB0AT Na+-dependent neutral amino acid transporterEAAT3 excitatory amino acid transporter-3ASCT1 alanine, serine, cysteine and threonine transporter-1CAT1 cationic amino acid transporter-1CAT2 cationic amino acid transporter-2LAT1 L type amino acid transportery+LAT1 y+ L amino acid transporter-1y+LAT2 y+ L amino acid transporter-2PepT1 peptide transporter-1APN aminopeptidase NSI sucrase isomaltaseGLUT2 glucose transporter-2GLUT5 glucose transporter-5SGLT1 sodium glucose transporter-1NPT2b type II sodium-dependent phosphate cotransporterZNT1 zinc transporter-1
qRT-PCR expression of genes encoding: •digestive enzymes •amino acid transporters•peptide transporters•sugar transporters•mineral transporters
transporters located atbrushborder basolateral membranes of enterocytes
CONSEQUENCES: ABSORPTION OF NUTRIENTS
![Page 44: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/44.jpg)
*
ZINC transporter -1
-located at basolateral membrane
-exports zinc: cell circulation
ZINC= essential micronutrient enzyme activities DNA and protein synthesis inhibitor of apoptosis and oxidative stress
↓ expression intracellular zinc concentration is preserved during e.g. oxidative stress evoked by DON (Osselaere et al., 2013)
CONSEQUENCES: ABSORPTION OF NUTRIENTS
![Page 45: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/45.jpg)
N = 6
blankfeed
100 µg/kg T-2 contaminated feed
(<250 µg/kg (2013/165/EC))
N = 6
3 weeks
1 week acclimatisation
CONSEQUENCES: ABSORPTION OF ANTIBIOTICS
Oral bolus chlortetracycline (20 mg/kg BW)
Blood samples: 0 - 0.5 – 1 - 1.5 – 2 – 3 – 4 – 6 – 8 – 12 - 24 h post administration and analysis with HPLC-UV
![Page 46: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/46.jpg)
CONSEQUENCES: ABSORPTION OF ANTIBIOTICS
Plasma concentration-time profile of chlortetracycline
Goossens et al., 2013
Significant increased plasma concentrations after intake of T-2 contaminated feed for 3 weeks
Effect on tissue concentrations of antibiotics?Therapeutic efficacy and public health?
↓
![Page 47: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/47.jpg)
TRANSFER OF MYCOTOXINS TO ANIMAL FOOD PRODUCTS
![Page 48: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/48.jpg)
TRANSFER FACTORS IN FOOD-PRODUCING ANIMALS
![Page 49: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/49.jpg)
TRANSFER FACTORS IN FOOD-PRODUCING ANIMALS
![Page 50: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/50.jpg)
TRANSFER FACTORS IN FOOD-PRODUCING ANIMALS
![Page 51: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/51.jpg)
TRANSFER FACTORS IN FOOD-PRODUCING ANIMALS
![Page 52: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/52.jpg)
TRANSFER FACTORS IN FOOD-PRODUCING ANIMALS
![Page 53: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/53.jpg)
FURTHER NEEDS
Effect on oral absorption of drugs,
coccidiostats and other mycotoxins:
increased passage?
Altered intestinal functions
Effect of mycotoxins on intestinal
microbiota and pathogens?
Fate of masked mycotoxins: in vivo hydrolysis of these conjugated forms?
Effect of other mycotoxins and co-contaminants on the gastro-intestinal tract
DON-3-glucoside
![Page 54: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/54.jpg)
•Feed contamination: 1 mycotoxin << multimycotoxin (1+1 = sometimes 3)
•Effect of high contamination levels of the feed (rare) on animal health is mostly known, however the effects of low to moderate contamination levels (frequently occurring) is less well-known
•Even low contamination levels (< max. EU guidance levels) can have a negative effect on poultry, pigs, …
•Economic impact of mycotoxins ≠ animals with clinical mycotoxicosis
TAKE-HOME MESSAGES
![Page 55: MYCOTOXINS and ANIMAL HEALTH: focus on intestinal health](https://reader038.fdocuments.net/reader038/viewer/2022103110/547b26e8b4af9f306c8b4860/html5/thumbnails/55.jpg)
•Negative impact on the intestinal morphology and function: -enhanced susceptibility for infectious diseases-altered digestion and absorption of nutrients-altered absorption of veterinary drugs
•Modulate the immune response
•(Partial) hydrolysis of masked DON and release of native DON in poultry and pigs
•Limited transfer of residues to animal food products, except e.g. for aflatoxin B1 (M1) to milk and ochratoxin A to kidney tissue
TAKE-HOME MESSAGES